NCT02328339

Brief Summary

The study will explore the benefit of tea for microcirculation. Subjects will consume tea ar a placebo matched for taste and appearance in a blinded cross over design.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2015

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 19, 2014

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 31, 2014

Completed
1 day until next milestone

Study Start

First participant enrolled

January 1, 2015

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2015

Completed
Last Updated

August 31, 2015

Status Verified

August 1, 2015

Enrollment Period

7 months

First QC Date

December 19, 2014

Last Update Submit

August 28, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Forearm blood flow response to acetylcholine

    Does tea ingestion change mean forearm blood flow response to acetylcholine when compared to placebo

    During acetylcholine infusion 120-140 min after first tea/placebo intake

Secondary Outcomes (2)

  • Forearm blood flow response to sodium nitropusside

    During sodium nitropusside infusion 170-190 min after first tea/placebo intake

  • Forearm blood flow response to L-NMMA

    During L-NMMA infusion 220-240 min after first tea/placebo intake

Study Arms (2)

Black tea

EXPERIMENTAL

Approximately 400 mg total polyphenols in 240 ml hot water (loading dose; 2 hours before the start of measurements; t=0) and 130 mg total polyphenols in 120 ml hot water (maintenance dose just before start of the measurements; t=120 min)

Other: Tea

Placebo

PLACEBO COMPARATOR

Caramel colour, maltodextrin and tea flavour in 240 ml hot water (2 hours before the start of measurements; t=0) and 120 ml hot water (maintenance dose just before start of the measurements; t=120 min)

Other: Placebo

Interventions

TeaOTHER

Black tea infusion equivalent to approximately 530 mg total polyphenols expressed as gallic acid equivalents

Black tea
PlaceboOTHER

Placebo matched to tea with respect to taste and appearance

Placebo

Eligibility Criteria

Age45 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Males and post menopausal (\> 1 years) females
  • Aged ≥ 45 and ≤ 75 years
  • Body mass index (BMI) of ≥ 18.0 and ≤ 35.0 kg/m2
  • Judged to be in good health on the basis of medical history, physical examination and routine laboratory tests (total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, glucose, highly sensitive C-reactive protein).
  • Normal blood coagulation as assessed by routine lab tests

You may not qualify if:

  • Strenuous exercise \> 2 hours per week. Strenuous exercise is defined as exercise which induces sweating and causes sufficient breathlessness to limit conversation
  • Current smoker or has stopped smoking less than 6 months before start of study
  • Self reported alcohol intake of \> 21 units/week)
  • Established cardiovascular disease or clinically significant arrhythmia
  • Diabetes mellitus
  • Blood pressure \> 160/100 mmHg
  • Taking medication that might affect endothelial function (as judged by the PI)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Greyling A, Wolters TLC, de Bresser DM, Roerink SHPP, Riksen NP, Mulder TP, Rowson MJ, Hopman MT, Thijssen DHJ. The acute effect of black tea consumption on resistance artery endothelial function in healthy subjects. A randomized controlled trial. Clin Nutr ESPEN. 2018 Feb;23:41-47. doi: 10.1016/j.clnesp.2017.10.011. Epub 2017 Nov 8.

MeSH Terms

Interventions

Tea

Intervention Hierarchy (Ancestors)

Plant PreparationsBiological ProductsComplex MixturesBeveragesDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Sean Roerink, Dr.

    Radboud University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 19, 2014

First Posted

December 31, 2014

Study Start

January 1, 2015

Primary Completion

August 1, 2015

Study Completion

August 1, 2015

Last Updated

August 31, 2015

Record last verified: 2015-08